Characteristics of Reported Gonorrhea Diagnoses During The COVID-19 Pandemic Compared With Pre-COVID-19 Pandemic, Baltimore City, Maryland
Sexual health service disruptions due to COVID-19 mitigation measures may have decreased gonorrhea screening and biased case-ascertainment toward symptomatic individuals. We assessed changes in reported symptoms and other characteristics among reported gonorrhea cases during pandemic versus prepande...
Saved in:
| Published in: | Sexually transmitted diseases Vol. 50; no. 4; p. 215 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.04.2023
|
| Subjects: | |
| ISSN: | 1537-4521, 1537-4521 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Sexual health service disruptions due to COVID-19 mitigation measures may have decreased gonorrhea screening and biased case-ascertainment toward symptomatic individuals. We assessed changes in reported symptoms and other characteristics among reported gonorrhea cases during pandemic versus prepandemic periods in 1 city with persistent gonorrhea transmission.
Enhanced surveillance data collected on a random sample of gonorrhea cases reported to the Baltimore City Health Department between March 2018 and September 2021 was used. Logistic regression assessed differences in case characteristics by diagnosis period (during pandemic: March 2020-September 2021; prepandemic: March 2018-September 2019).
Analyses included 2750 (1090 during pandemic, 1660 prepandemic) gonorrhea cases, representing 11,904 reported cases. During pandemic versus prepandemic, proportionally fewer cases were reported by sexual health clinics (8.8% vs 23.2%), and more frequently reported by emergency departments/urgent care centers (23.3% vs 11.9%). Adjusting for diagnosing provider, fewer cases who were men with urethral infections (adjusted odds ratio [aOR], 0.65; 95% confidence interval [CI], 0.55-0.77), aged <18 years (aOR, 0.64; 95% CI, 0.47-0.89), and women (aOR, 0.84; 95% CI, 0.71-0.99) were reported, and cases with insurance (aOR, 1.85; 95% CI, 1.40-2.45), living with human immunodeficiency virus (aOR, 1.43; 95% CI, 1.12-1.83), or recent (≤12 months) gonorrhea history (aOR, 1.25; 95% CI, 1.02-1.53) were more frequently reported during pandemic versus prepandemic. Reported symptoms and same-day/empiric treatment did not differ across periods.
We observed no changes in reported symptoms among cases diagnosed during pandemic versus prepandemic. Increased frequency of reported diagnoses who were insured, living with human immunodeficiency virus, or with recent gonorrhea history are suggestive of differences in care access and care-seeking behaviors among populations with high gonorrhea transmission during the pandemic. |
|---|---|
| AbstractList | Sexual health service disruptions due to COVID-19 mitigation measures may have decreased gonorrhea screening and biased case-ascertainment toward symptomatic individuals. We assessed changes in reported symptoms and other characteristics among reported gonorrhea cases during pandemic versus prepandemic periods in 1 city with persistent gonorrhea transmission.BACKGROUNDSexual health service disruptions due to COVID-19 mitigation measures may have decreased gonorrhea screening and biased case-ascertainment toward symptomatic individuals. We assessed changes in reported symptoms and other characteristics among reported gonorrhea cases during pandemic versus prepandemic periods in 1 city with persistent gonorrhea transmission.Enhanced surveillance data collected on a random sample of gonorrhea cases reported to the Baltimore City Health Department between March 2018 and September 2021 was used. Logistic regression assessed differences in case characteristics by diagnosis period (during pandemic: March 2020-September 2021; prepandemic: March 2018-September 2019).METHODSEnhanced surveillance data collected on a random sample of gonorrhea cases reported to the Baltimore City Health Department between March 2018 and September 2021 was used. Logistic regression assessed differences in case characteristics by diagnosis period (during pandemic: March 2020-September 2021; prepandemic: March 2018-September 2019).Analyses included 2750 (1090 during pandemic, 1660 prepandemic) gonorrhea cases, representing 11,904 reported cases. During pandemic versus prepandemic, proportionally fewer cases were reported by sexual health clinics (8.8% vs 23.2%), and more frequently reported by emergency departments/urgent care centers (23.3% vs 11.9%). Adjusting for diagnosing provider, fewer cases who were men with urethral infections (adjusted odds ratio [aOR], 0.65; 95% confidence interval [CI], 0.55-0.77), aged <18 years (aOR, 0.64; 95% CI, 0.47-0.89), and women (aOR, 0.84; 95% CI, 0.71-0.99) were reported, and cases with insurance (aOR, 1.85; 95% CI, 1.40-2.45), living with human immunodeficiency virus (aOR, 1.43; 95% CI, 1.12-1.83), or recent (≤12 months) gonorrhea history (aOR, 1.25; 95% CI, 1.02-1.53) were more frequently reported during pandemic versus prepandemic. Reported symptoms and same-day/empiric treatment did not differ across periods.RESULTSAnalyses included 2750 (1090 during pandemic, 1660 prepandemic) gonorrhea cases, representing 11,904 reported cases. During pandemic versus prepandemic, proportionally fewer cases were reported by sexual health clinics (8.8% vs 23.2%), and more frequently reported by emergency departments/urgent care centers (23.3% vs 11.9%). Adjusting for diagnosing provider, fewer cases who were men with urethral infections (adjusted odds ratio [aOR], 0.65; 95% confidence interval [CI], 0.55-0.77), aged <18 years (aOR, 0.64; 95% CI, 0.47-0.89), and women (aOR, 0.84; 95% CI, 0.71-0.99) were reported, and cases with insurance (aOR, 1.85; 95% CI, 1.40-2.45), living with human immunodeficiency virus (aOR, 1.43; 95% CI, 1.12-1.83), or recent (≤12 months) gonorrhea history (aOR, 1.25; 95% CI, 1.02-1.53) were more frequently reported during pandemic versus prepandemic. Reported symptoms and same-day/empiric treatment did not differ across periods.We observed no changes in reported symptoms among cases diagnosed during pandemic versus prepandemic. Increased frequency of reported diagnoses who were insured, living with human immunodeficiency virus, or with recent gonorrhea history are suggestive of differences in care access and care-seeking behaviors among populations with high gonorrhea transmission during the pandemic.CONCLUSIONSWe observed no changes in reported symptoms among cases diagnosed during pandemic versus prepandemic. Increased frequency of reported diagnoses who were insured, living with human immunodeficiency virus, or with recent gonorrhea history are suggestive of differences in care access and care-seeking behaviors among populations with high gonorrhea transmission during the pandemic. Sexual health service disruptions due to COVID-19 mitigation measures may have decreased gonorrhea screening and biased case-ascertainment toward symptomatic individuals. We assessed changes in reported symptoms and other characteristics among reported gonorrhea cases during pandemic versus prepandemic periods in 1 city with persistent gonorrhea transmission. Enhanced surveillance data collected on a random sample of gonorrhea cases reported to the Baltimore City Health Department between March 2018 and September 2021 was used. Logistic regression assessed differences in case characteristics by diagnosis period (during pandemic: March 2020-September 2021; prepandemic: March 2018-September 2019). Analyses included 2750 (1090 during pandemic, 1660 prepandemic) gonorrhea cases, representing 11,904 reported cases. During pandemic versus prepandemic, proportionally fewer cases were reported by sexual health clinics (8.8% vs 23.2%), and more frequently reported by emergency departments/urgent care centers (23.3% vs 11.9%). Adjusting for diagnosing provider, fewer cases who were men with urethral infections (adjusted odds ratio [aOR], 0.65; 95% confidence interval [CI], 0.55-0.77), aged <18 years (aOR, 0.64; 95% CI, 0.47-0.89), and women (aOR, 0.84; 95% CI, 0.71-0.99) were reported, and cases with insurance (aOR, 1.85; 95% CI, 1.40-2.45), living with human immunodeficiency virus (aOR, 1.43; 95% CI, 1.12-1.83), or recent (≤12 months) gonorrhea history (aOR, 1.25; 95% CI, 1.02-1.53) were more frequently reported during pandemic versus prepandemic. Reported symptoms and same-day/empiric treatment did not differ across periods. We observed no changes in reported symptoms among cases diagnosed during pandemic versus prepandemic. Increased frequency of reported diagnoses who were insured, living with human immunodeficiency virus, or with recent gonorrhea history are suggestive of differences in care access and care-seeking behaviors among populations with high gonorrhea transmission during the pandemic. |
| Author | Coen, Michelle E Muvva, Ravikiran Genberg, Becky Williford, Sarah L Schumacher, Christina M Greenbaum, Adena |
| Author_xml | – sequence: 1 givenname: Michelle E surname: Coen fullname: Coen, Michelle E organization: From the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health – sequence: 2 givenname: Sarah L surname: Williford fullname: Williford, Sarah L – sequence: 3 givenname: Ravikiran surname: Muvva fullname: Muvva, Ravikiran organization: Baltimore City Health Department, Baltimore, MD – sequence: 4 givenname: Becky surname: Genberg fullname: Genberg, Becky organization: From the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health – sequence: 5 givenname: Adena surname: Greenbaum fullname: Greenbaum, Adena organization: Baltimore City Health Department, Baltimore, MD – sequence: 6 givenname: Christina M surname: Schumacher fullname: Schumacher, Christina M organization: Center for Child and Community Health Research, Johns Hopkins School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36473236$$D View this record in MEDLINE/PubMed |
| BookMark | eNplkFFLwzAUhYNMnJv-A5E8-rDOpkmT9lE7nYPJpkx9LGlyu0bWZibdw_6Cv9qCEwbel3vgfudwuAPUa2wDCF2RcEzCVNwu5i_j8GiIiMMTdE5iKgIWR6R3pPto4P1nx7AkJGeoTzkTNKL8HH1nlXRSteCMb43y2Jb4FbbWtaDx1DbWuQoknhi5bqwHjyc7Z5o1XlWAs8X7bBKQFC9lo6E2Cme23krXOT9MW-Glg-AfM8L3ctOa2rouwLT7EX6Wbr_prhfotJQbD5eHPURvjw-r7CmYL6az7G4eKJZEPCig0EJzJWnEE0lUHHIKqlApF5BylsiS6KIoQk1LYLSME6kTrXisWBmlSspoiG5-c7fOfu3At3ltvIJN1wHszueREIwykfC0Q68P6K6oQedbZ-qubf73v-gHRF11Hg |
| CitedBy_id | crossref_primary_10_3390_v15091843 crossref_primary_10_1016_j_eimce_2025_02_001 crossref_primary_10_1016_j_eimc_2024_11_008 |
| ContentType | Journal Article |
| Copyright | Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/OLQ.0000000000001750 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1537-4521 |
| ExternalDocumentID | 36473236 |
| Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
| GeographicLocations | Baltimore |
| GeographicLocations_xml | – name: Baltimore |
| GrantInformation_xml | – fundername: ACL HHS grantid: R43PS005187 – fundername: NCHHSTP CDC HHS grantid: H25 PS004259 – fundername: NCHHSTP CDC HHS grantid: R43 PS005187 |
| GroupedDBID | --- -ET ..I .XZ .Z2 01R 0R~ 123 1J1 354 40H 4Q1 4Q2 4Q3 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAYEP ABASU ABBUW ABDIG ABHFT ABJNI ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADGHP ADHPY AE6 AEBDS AENEX AFBFQ AFDTB AFEXH AFMBP AFNMH AFRAH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASUFR BKOMP BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 E.X EBS ECM EEVPB EIF ERAAH EX3 F2M F2N F5P FCALG FL- FRP GNXGY GQDEL H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 L-C L7B LMP NPM N~7 N~B O9- OAG OAH OBH ODMTH OHH OHYEH OK1 OLB OLG OLH OLU OLY OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWV OWW OWZ OXXIT P2P PQQKQ RIG RLZ RXW S4R S4S TAE TEORI TR2 TSPGW V2I VVN W2D W3M WH7 WOQ WOW X3V X3W XFW XYM YFH YOC ZFV ZY1 7X8 ADKSD ADSXY |
| ID | FETCH-LOGICAL-c4826-bebd7d6ca3268a1c5063ecbc967e9648af1dbbb0d3fe43f58ad8dc65c4f29caa2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00007435-202304000-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1537-4521 |
| IngestDate | Thu Oct 02 08:01:33 EDT 2025 Mon Jul 21 06:08:12 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4826-bebd7d6ca3268a1c5063ecbc967e9648af1dbbb0d3fe43f58ad8dc65c4f29caa2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC10009801 |
| PMID | 36473236 |
| PQID | 2774347869 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2774347869 pubmed_primary_36473236 |
| PublicationCentury | 2000 |
| PublicationDate | 20230401 |
| PublicationDateYYYYMMDD | 2023-04-01 |
| PublicationDate_xml | – month: 4 year: 2023 text: 20230401 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Sexually transmitted diseases |
| PublicationTitleAlternate | Sex Transm Dis |
| PublicationYear | 2023 |
| SSID | ssj0014801 |
| Score | 2.3938718 |
| Snippet | Sexual health service disruptions due to COVID-19 mitigation measures may have decreased gonorrhea screening and biased case-ascertainment toward symptomatic... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 215 |
| SubjectTerms | Baltimore - epidemiology COVID-19 - epidemiology Female Gonorrhea - diagnosis Gonorrhea - epidemiology Homosexuality, Male Humans Male Pandemics |
| Title | Characteristics of Reported Gonorrhea Diagnoses During The COVID-19 Pandemic Compared With Pre-COVID-19 Pandemic, Baltimore City, Maryland |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36473236 https://www.proquest.com/docview/2774347869 |
| Volume | 50 |
| WOSCitedRecordID | wos00007435-202304000-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwGA3qRHzxfpk3Ivi4sPWSNHkS7ZwKbqvgZW8lt-JA29lNwb_grzZpO4aIINiHPrVQ0i9fTr7v5BwATrCTCOYKilqJay3MCEUcY40EEw5WIuB-SxVmE0GvRwcDFlUFt3FFq5zmxCJRq0zaGnnTNTjF8wNK2OnoFVnXKNtdrSw05kHNM1DGUrqCwayLYKVRSr1Uq-3tOtOjcyxo9m9uS-nC6jKraOt3kFksNp3V_37mGlipYCY8K-NiHczpdAMsdatG-ib4DL8LNcMsgSUW1wpeZmmW5yZLw3ZJxNNj2C6OM0ITVTDsP1y3kcNgZAvQL0MJw4rIDh-HkycY5Rr9eKYBz_nzZGhpvTA0yL8Buzz_sLTKLXDfubgLr1Bly4CkbzYjSGihAkUkN8iPckdig3K0FJKRQDPiU544SgjRUl6ifS_BlCuqJMHSN-EgOXe3wUKapXoXQEUS7XHGXM4MDnI415RKqhnGmBOzRa6D4-koxybsbS-Dpzp7G8ezca6DnfJXxaNSnyO2kvie65G9P7y9D5atgXzJxTkAtcRMen0IFuX7ZDjOj4p4Mvde1P0CANjUVQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characteristics+of+Reported+Gonorrhea+Diagnoses+During+The+COVID-19+Pandemic+Compared+With+Pre-COVID-19+Pandemic%2C+Baltimore+City%2C+Maryland&rft.jtitle=Sexually+transmitted+diseases&rft.au=Coen%2C+Michelle+E&rft.au=Williford%2C+Sarah+L&rft.au=Muvva%2C+Ravikiran&rft.au=Genberg%2C+Becky&rft.date=2023-04-01&rft.issn=1537-4521&rft.eissn=1537-4521&rft.volume=50&rft.issue=4&rft.spage=215&rft_id=info:doi/10.1097%2FOLQ.0000000000001750&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-4521&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-4521&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-4521&client=summon |